Literature DB >> 16246432

Universal newborn hearing screening follow-up in two Georgia populations: newborn, mother and system correlates.

N Wendell Todd1.   

Abstract

BACKGROUND: Nearly half of babies who "fail" their newborn hearing screening do not receive appropriate follow-up. Various explanations have been suggested.
OBJECTIVE: To investigate, in two contrasting populations of newborns in Georgia, contemporaneous medical, socio-demographic and screening correlates of follow-up after newborn hearing screening. Three hypotheses were addressed: (1) follow-up correlated with particular medical, social and demographic features; (2) screening performance indicators correlated with follow-up; and (3) screening policies and procedures correlated with follow-up.
METHODS: The studied babies, born July 2001 through June 2003 at Atlanta's Piedmont Hospital and Waycross Health District, had failed screening in both ears. Each site had about 4000 births per year, and a plan for outpatient follow-up of in-patient "fail" babies.
RESULTS: At Piedmont, where Medicaid funded less than 7% of the births, 57% (130/230) had known follow-up to outpatient screening. In contrast, at Waycross, where Medicaid funded 89.6% of the births, 100% (38/38) had follow-up. The first study hypothesis was only partially supported by the data-from Piedmont, but not Waycross. White race and maternal age 30 years or older correlated with following-up: odds ratios 2.07 (95% CI 1.17, 3.68) and 1.83 (1.05, 3.17), respectively. Private health insurance and marriage trended with following-up. Follow-up rates did not correlate with the rates of screening refusal, missed screening and "fail" rates. Follow-up was unrelated to mothers witnessing the screening, receiving in-person explanations and having appointments arranged for them. The Piedmont and Waycross programs were quite different. Piedmont's began in 2001, mothers typically learned about screening when it was done and "fail" babies were reported to many public health entities. In contrast, the Waycross program was more than 20 years old, prenatal care included teaching about screening and reporting was to one public health entity.
CONCLUSIONS: Though maternal socio-demographic features (poor, non-white, young) and access problems have been considered factors for non-follow-up, this study found two program characteristics most important: the lack of prenatal education about newborn hearing screening, and the lack of functionally integrated hospital hearing information with Public Health.

Entities:  

Mesh:

Year:  2005        PMID: 16246432     DOI: 10.1016/j.ijporl.2005.09.019

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Impact of co-occurring birth defects on the timing of newborn hearing screening and diagnosis.

Authors:  Derek A Chapman; Caroline C Stampfel; Joann N Bodurtha; Kelley M Dodson; Arti Pandya; Kathleen B Lynch; Russell S Kirby
Journal:  Am J Audiol       Date:  2011-09-22       Impact factor: 1.493

2.  Influence of the WIC Program on Loss to Follow-up for Newborn Hearing Screening.

Authors:  Lisa L Hunter; Jareen Meinzen-Derr; Susan Wiley; Carrie L Horvath; Reena Kothari; Scott Wexelblatt
Journal:  Pediatrics       Date:  2016-06-15       Impact factor: 7.124

3.  Geospatial Analysis of Risk Factors Contributing to Loss to Follow-up in Cleft Lip/Palate Care.

Authors:  Banafsheh Sharif-Askary; Peter G Bittar; Alfredo E Farjat; Beiyu Liu; Joao Ricardo Nickenig Vissoci; Alexander C Allori
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-09-14

4.  Audiological follow-up in a risk-based newborn hearing screening programme: An exploratory study of the influencing factors.

Authors:  Amisha Kanji; Kirsten Krabbenhoft
Journal:  S Afr J Commun Disord       Date:  2018-10-25

Review 5.  Overview of newborn hearing screening programs in Brazilian maternity hospitals.

Authors:  Hannalice Gottschalck Cavalcanti; Luciana Pimentel Fernandes de Melo; Laisa Flávia Soares Fernandes Peixoto Buarque; Ricardo Oliveira Guerra
Journal:  Braz J Otorhinolaryngol       Date:  2014-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.